What Is Peptide Mapping?
Principles of the Test
Peptide mapping is an advanced analytical technique used to confirm protein identity, sequence integrity, and structural modifications. It works by digesting proteins into peptides, separating them by chromatography, and analyzing them with high-resolution mass spectrometry.
Eagle’s intact mass and peptide mapping services combine state-of-the-art mass spectrometry and expert scientific interpretation to deliver clear, reliable, actionable insight across the biotherapeutic lifecycle from early development through commercial manufacturing.
Read more about Peptide Mapping
How Peptide Mapping Works?
Discover peptide mapping with Eagle Analytical
Step 1: Protein Digestion
The protein sample is enzymatically digested using trypsin or other site-specific proteases into predictable peptide fragments.
Step 2:Chromatographic Separation
The resulting peptides are separated by liquid chromatography (LC), allowing complex mixtures to be resolved with high precision.
Step 3: Mass Spectrometric Analysis
Each peptide is analyzed by mass spectrometry (MS and MS/MS) to determine:
1. Molecular weight
2. Amino acid sequence
3. Post-translational modifications (PTMs)
Step 4: Data Interpretation & Sequence Coverage
Peptide masses and fragmentation patterns are matched to theoretical protein sequences, producing:
1. High sequence coverage
2. Confirmation of protein identity
3. Localization of modifications or variants
Why is Peptide Mapping Important for Protein Characterization?
Small changes in protein structure can affect the safety and performance of biotherapeutic products. Peptide mapping helps scientists confirm that a protein has the correct structure and sequence. It is a key method used for protein characterization in biopharmaceutical research.
Peptide mapping confirms the primary amino acid sequence and provides high sequence coverage. It also detects post-translational modifications (PTMs) such as oxidation, deamidation, acetylation, glycosylation, and changes in disulfide bonds.
This method can also identify protein variants, truncations, impurities, and degradation products. Early detection of these changes helps reduce development risk and supports informed decision-making during process development and manufacturing. Detecting these changes early helps reduce development risk and supports better decisions during process development and manufacturing.
Because of its specificity and ability to provide detailed sequence-level information, peptide mapping is widely used for quality control, comparability studies, and regulatory submissions. It is commonly applied to monoclonal antibodies, recombinant proteins, and other biologics throughout the product lifecycle. Learn More
When Do You Need Peptide Mapping?
Peptide mapping is essential whenever protein structure, identity, or consistency must be
confirmed — especially in regulated or high-risk environments.
Biotherapeutic Development
• Monoclonal antibodies
• Recombinant proteins
• Fusion proteins
Comparability Studies
• Process changes
• Manufacturing site transfers
• Lot-to-lot consistency
Quality Control & Release Testing
• Structural confirmation
• Degradation monitoring
Research Applications
• Protein variants
• Unknown modifications
• Stress and stability studies
Regulatory Submissions
• Method validation and characterization packages
Peptide Mapping Applications Summary
- Biotherapeutic characterization (mAbs, recombinant proteins, fusion proteins)
- Lot-to-lot and process change comparability
- Regulatory submission support
- Quality control and release testing
- Stability, stress, and root-cause studies
Peptide Mapping in Biotherapeutic Development
Why Peptide Mapping Matters in Biotherapeutic Development
Peptide mapping is an important analytical method used for protein characterization in biopharmaceutical research and development. It helps confirm protein identity, verify the intact molecular weight, and provide high sequence coverage by analyzing peptides.
This technique also allows scientists to detect and localize post-translational modifications (PTMs) and identify protein variants, truncations, and degradation products. By revealing structural changes early, peptide mapping helps reduce development risk and supports better decisions during process development and scale-up.
Regulatory agencies widely accept peptide mapping data for regulatory submissions, quality control, and product release testing. It is commonly used for monoclonal antibodies, recombinant proteins, and other complex biologics, supporting product development from early discovery through commercial manufacturing.
Read more about Peptide Mapping
Still Have Questions About Peptide Mapping?
Peptide mapping is a powerful tool for confirming protein identity, detecting post-translational modifications, and ensuring product consistency throughout the biopharmaceutical lifecycle. If you have questions about peptide mapping services, sample requirements, or how this analysis can support your development or regulatory strategy, our scientific team is here to help.
Contact Eagle Analytical to discuss your project, request more information, or speak with an expert about your peptide mapping needs.
